Literature DB >> 2261911

Surgery in the treatment of thyroid cancer.

M J Demeure1, O H Clark.   

Abstract

Patients with thyroid cancers offer a clinical challenge to the physician and surgeon for both treatment and research. It is evident that preoperative, intraoperative, and postoperative management can all favorably affect the clinical outcome. This demands close cooperation among internist, endocrinologist, radiotherapist, and surgeon. As surgeons, we advocate total thyroidectomy for most thyroid cancers, when it can be done safely, because recurrences will be minimized and the subsequent use of radioactive iodine treatment is facilitated. In the hands of an experienced thyroid surgeon, total thyroidectomy can be accomplished with a minimum of risk. In the future we hope to be able to identify patients at highest risk for aggressive tumor behavior and select these patients for the most aggressive treatment plans. In other cases early detection by surveillance of patients at risk for thyroid cancer, particularly medullary thyroid cancer, has already favorably affected prognosis by allowing treatment at an earlier stage of disease.

Entities:  

Mesh:

Year:  1990        PMID: 2261911

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  4 in total

Review 1.  Thyroid swelling--a protocol for management.

Authors:  W E Thomas
Journal:  J R Soc Med       Date:  1998       Impact factor: 5.344

2.  Preservation of recurrent laryngeal nerve invaded by differentiated thyroid cancer.

Authors:  T Nishida; K Nakao; M Hamaji; W Kamiike; K Kurozumi; H Matsuda
Journal:  Ann Surg       Date:  1997-07       Impact factor: 12.969

3.  Recurrent laryngeal nerve palsy in well-differentiated thyroid carcinoma: clinicopathologic features and outcome study.

Authors:  Wai-Fan Chan; Chung-Yau Lo; King-Yin Lam; Koon-Yat Wan
Journal:  World J Surg       Date:  2004-11       Impact factor: 3.352

4.  Total versus hemithyroidectomy for small unilateral papillary thyroid carcinoma.

Authors:  Dania Hirsch; Sigal Levy; Gloria Tsvetov; Ilan Shimon; Carlos Benbassat
Journal:  Oncol Lett       Date:  2013-12-18       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.